secwatch.observer — SEC 8-K summary
======================================

Issuer:     HERBALIFE LTD. (HLF)
CIK:        0001180262
Form:       8-K
Filed at:   2025-04-30T23:59:59+00:00
Accession:  0001213900-25-037675
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Herbalife Q1 net sales $1.2B (down 3.4% YoY), adjusted EBITDA $164.9M beats guidance
--------------------------------------------------------------------------------

- Net sales $1.2B at midpoint of guidance; down 3.4% YoY but up 1.4% on constant-currency basis.
- Net income $50.4M; adjusted net income $59.9M; diluted EPS $0.49, adjusted diluted EPS $0.59.
- Adjusted EBITDA $164.9M exceeds guidance; margin up 260 bps vs Q1 '24; leverage ratio reduced to 3.0x.
- Full-year 2025 guidance revised: net sales range narrowed, adjusted EBITDA raised, capex reduced.
- Completed acquisitions of Pro2col Health and Pruvit Ventures; formed HBL Link Bioscience with 51% ownership.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1180262/000121390025037675/0001213900-25-037675-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1180262/000121390025037675/ea0240048-8k_herbalife.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-037675

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer